Fig. 1From: miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancerClinical study design. Met Lung metastasis, Tumor Primary breast carcinoma, miRNA MicroRNA, Normal Normal adjacent breast tissue, RT-PCR Reverse transcription polymerase chain reaction; TNBC Triple-negative breast cancerBack to article page